Influence of Oxidation Conditions on the Yield of 2-Substituted Imidazole-4,5-dicarboxylic Acids
摘要:
Conditions were found which allow 2-alkyl-substituted imidazole-4,5-dicarboxylic acids to be synthesized in preparative quantities by the oxidation of 2-alkylbenzimidazoles with hydrogen peroxide. It was shown that optimal results can be obtained at the concentration of 2-alkylimidazole in sulfuric acid of 1 M and the hydrogen peroxide: 2-alkylbenzimidazole molar ratio of 11: 1. Oxidation under these conditions results in higher yields of the target 2-alkylimidazole-4,5-dicarboxylic acids, including those with a branched alkyl group.
Substituted benzazoloporphyrazines for polymerization and surface attachment and articles formed therefrom
申请人:Youngblood W. Justin
公开号:US20110015388A1
公开(公告)日:2011-01-20
The present invention provides an article of manufacture formed from a substrate and a benzazoloporphyrazine bound to the substrate. The article may take a variety of different forms and may be for example an electrochromic display, a molecular capacitor, a battery, a solar cell, or a molecular memory device. Methods of making such articles, along with compounds, methods and intermediates useful for making such benzazoloporphyrazines, are also described.
Air-stable Ruthenium(II)-NNN Pincer Complexes for the Efficient Coupling of Aromatic Diamines and Alcohols to 1<i>H</i>
-benzo[<i>d</i>
]imidazoles with the Liberation of H<sub>2</sub>
Two new phosphine‐free RuII‐NNN pincer complexes ([RuCl(L1)(CH3CN)2]Cl (1) and [RuCl(L2)(CH3CN)2]Cl (2) [L1=2,6‐bis(1H‐imidazole‐2‐yl)pyridine, L2=2,6‐bis(1‐hexyl‐1H‐imidazole‐2‐yl)pyridine] were synthesized to catalyze the condensation of benzyl alcohol and benzene‐1,2‐diamine homogeneously to 2‐pheny‐1H‐benzo[d]imidazole and H2. The reactivity in the order of 1>2 is lower than that of the phosphine‐containing
[EN] SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF<br/>[FR] PETITES MOLÉCULES AGONISTES DE LA MUCOLIPINE 1 ET LEURS UTILISATIONS
申请人:UNIV MICHIGAN REGENTS
公开号:WO2021041866A1
公开(公告)日:2021-03-04
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a phenyl-sulfonic amide (or similar) structure which function as agonists of mucolipin 1 (ML1), and their use as therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and related disorders.
One-Pot Synthesis of Functionalized Benzimidazoles and 1H-Pyrimidines via Cascade Reactions of o-Aminoanilines or Naphthalene-1,8-diamine with Alkynes and p-Tolylsulfonyl Azide
作者:Yanguang Wang、Jin She、Zheng Jiang
DOI:10.1055/s-0029-1217515
日期:2009.7
A one-potsynthesis of functionalized benzimidazoles and 1H-pyrimidines via the cascadereactions of o-aminoanilines or naphthalene-1,8-diamine with terminal alkynes and p-tolylsulfonyl azide is reported. The protocol is efficient and general.
Cooperative iridium complex-catalyzed synthesis of quinoxalines, benzimidazoles and quinazolines in water
作者:Kaushik Chakrabarti、Milan Maji、Sabuj Kundu
DOI:10.1039/c8gc03744b
日期:——
Herein, an efficient methodology for the synthesis of a diverse class of N-heterocyclic moieties, such as quinoxalines, benzimidazoles and quinazolines, was developed in water using bio-renewable alcohols. The quinoxalines were successfully synthesized from a wide range of diamines and nitroamines with diols in air. Interestingly, benzimidazoles and quinazolines were synthesized with excellent isolated